Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide

Hyperoxia: good or bad for the injured brain?

(2009) Michael N Diringer   Current Opinion in Critical Care

Tissue pO2 of Orthotopic 9L and C6 Gliomas and Tumor-Specific Response to Radiotherapy and Hyperoxygenation

(2009) Nadeem Khan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas

(2009) Rolf F. Barth et al.   JOURNAL OF NEURO-ONCOLOGY

Effect of trans sodium crocetinate on brain tumor oxgenation

(2009) Jason Sheehan et al.   JOURNAL OF NEUROSURGERY

Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival

(2008) A. M. Spence et al.   CLINICAL CANCER RESEARCH

Trans-sodium crocetinate for treating hypoxia/ischemia

(2008) John L Gainer   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation

(2008) Jason Sheehan et al.   JOURNAL OF NEUROSURGERY

Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts

(2008) Shin-Ichiro Sugiyama et al.   NEUROLOGICAL RESEARCH

THE NEW LICOX COMBINED BRAIN TISSUE OXYGEN AND BRAIN TEMPERATURE MONITOR

(2008) Campbell Stewart et al.   NEUROSURGERY